280 related articles for article (PubMed ID: 23152813)
1. Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics.
Zhou X; Mao J; Ai J; Deng Y; Roth MR; Pound C; Henegar J; Welti R; Bigler SA
PLoS One; 2012; 7(11):e48889. PubMed ID: 23152813
[TBL] [Abstract][Full Text] [Related]
2. Identification of plasma lipid species as promising diagnostic markers for prostate cancer.
Chen X; Zhu Y; Jijiwa M; Nasu M; Ai J; Dai S; Jiang B; Zhang J; Huang G; Deng Y
BMC Med Inform Decis Mak; 2020 Sep; 20(Suppl 9):223. PubMed ID: 32967667
[TBL] [Abstract][Full Text] [Related]
3. Prostate Cancer Associated Lipid Signatures in Serum Studied by ESI-Tandem Mass Spectrometryas Potential New Biomarkers.
Duscharla D; Bhumireddy SR; Lakshetti S; Pospisil H; Murthy PV; Walther R; Sripadi P; Ummanni R
PLoS One; 2016; 11(3):e0150253. PubMed ID: 26958841
[TBL] [Abstract][Full Text] [Related]
4. Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.
Yan F; Wen Z; Wang R; Luo W; Du Y; Wang W; Chen X
BMC Pulm Med; 2017 Dec; 17(1):174. PubMed ID: 29212488
[TBL] [Abstract][Full Text] [Related]
5. Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers.
Skotland T; Ekroos K; Kauhanen D; Simolin H; Seierstad T; Berge V; Sandvig K; Llorente A
Eur J Cancer; 2017 Jan; 70():122-132. PubMed ID: 27914242
[TBL] [Abstract][Full Text] [Related]
6. Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Chen X; Chen H; Dai M; Ai J; Li Y; Mahon B; Dai S; Deng Y
Oncotarget; 2016 Jun; 7(24):36622-36631. PubMed ID: 27153558
[TBL] [Abstract][Full Text] [Related]
7. A novel three serum phospholipid panel differentiates normal individuals from those with prostate cancer.
Patel N; Vogel R; Chandra-Kuntal K; Glasgow W; Kelavkar U
PLoS One; 2014; 9(3):e88841. PubMed ID: 24603597
[TBL] [Abstract][Full Text] [Related]
8. Differences in lipidomics may be potential biomarkers for early diagnosis of pancreatic cancer.
Zhou D; Mu D; Cheng M; Dou Y; Zhang X; Feng Z; Qiu G; Yu H; Chen Y; Xu H; Sun J; Zhou L
Acta Cir Bras; 2020 Jul; 35(5):e202000508. PubMed ID: 32638847
[TBL] [Abstract][Full Text] [Related]
9. Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.
Butler LM; Mah CY; Machiels J; Vincent AD; Irani S; Mutuku SM; Spotbeen X; Bagadi M; Waltregny D; Moldovan M; Dehairs J; Vanderhoydonc F; Bloch K; Das R; Stahl J; Kench JG; Gevaert T; Derua R; Waelkens E; Nassar ZD; Selth LA; Trim PJ; Snel MF; Lynn DJ; Tilley WD; Horvath LG; Centenera MM; Swinnen JV
Cancer Res; 2021 Oct; 81(19):4981-4993. PubMed ID: 34362796
[TBL] [Abstract][Full Text] [Related]
10. Lipidomics applications for discovering biomarkers of diseases in clinical chemistry.
Zhao YY; Cheng XL; Lin RC
Int Rev Cell Mol Biol; 2014; 313():1-26. PubMed ID: 25376488
[TBL] [Abstract][Full Text] [Related]
11. Distinct plasma lipids profiles of recurrent ovarian cancer by liquid chromatography-mass spectrometry.
Li J; Xie H; Li A; Cheng J; Yang K; Wang J; Wang W; Zhang F; Li Z; Dhillon HS; Openkova MS; Zhou X; Li K; Hou Y
Oncotarget; 2017 Jul; 8(29):46834-46845. PubMed ID: 27564116
[TBL] [Abstract][Full Text] [Related]
12. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.
Cheng F; Wen Z; Feng X; Wang X; Chen Y
Life Sci; 2020 Nov; 260():118489. PubMed ID: 32976882
[TBL] [Abstract][Full Text] [Related]
13. The association of prostatic lipids with progression, racial disparity and discovery of biomarkers in prostate cancer.
Zhou X; Mao J; Peng W; Chen Z; Mei H; Kyle P; Mo Y; Allen TC
Transl Oncol; 2021 Dec; 14(12):101218. PubMed ID: 34509951
[TBL] [Abstract][Full Text] [Related]
14. Plasma lipidomic profiles of kidney, breast and prostate cancer patients differ from healthy controls.
Wolrab D; Jirásko R; Peterka O; Idkowiak J; Chocholoušková M; Vaňková Z; Hořejší K; Brabcová I; Vrána D; Študentová H; Melichar B; Holčapek M
Sci Rep; 2021 Oct; 11(1):20322. PubMed ID: 34645896
[TBL] [Abstract][Full Text] [Related]
15. Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer.
Li J; Ren S; Piao HL; Wang F; Yin P; Xu C; Lu X; Ye G; Shao Y; Yan M; Zhao X; Sun Y; Xu G
Sci Rep; 2016 Feb; 6():20984. PubMed ID: 26865432
[TBL] [Abstract][Full Text] [Related]
16. A plasma lipidomics strategy reveals perturbed lipid metabolic pathways and potential lipid biomarkers of human colorectal cancer.
Shen S; Yang L; Li L; Bai Y; Cai C; Liu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():41-48. PubMed ID: 29028617
[TBL] [Abstract][Full Text] [Related]
17. Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort.
Adeola HA; Smith M; Kaestner L; Blackburn JM; Zerbini LF
Oncotarget; 2016 Mar; 7(12):13945-64. PubMed ID: 26885621
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Role of Preoperative Serum Lipid Levels in Patients Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer.
Wettstein MS; Saba K; Umbehr MH; Murtola TJ; Fankhauser CD; Adank JP; Hofmann M; Sulser T; Hermanns T; Moch H; Wild P; Poyet C
Prostate; 2017 Apr; 77(5):549-556. PubMed ID: 28093792
[TBL] [Abstract][Full Text] [Related]
19. Lipidomics, Biomarkers, and Schizophrenia: A Current Perspective.
Sethi S; Hayashi MA; Barbosa BS; Pontes JG; Tasic L; Brietzke E
Adv Exp Med Biol; 2017; 965():265-290. PubMed ID: 28132184
[TBL] [Abstract][Full Text] [Related]
20. STUDY OF LIPID BIOMARKERS OF PATIENTS WITH POLYPS AND COLORECTAL CÂNCER.
Serafim PVP; Figueiredo AG; Felipe AV; Turco EGL; Silva IDCGD; Forones NM
Arq Gastroenterol; 2019; 56(4):399-404. PubMed ID: 31800736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
